Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simbrinza for 24-hour IOP control in glaucoma and ocular hypertension
NCT01978600Phase 4Completed
- Sponsor
- Alcon Inc.
- Start
- Oct 2013
- Primary completion
- Mar 2014
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of brinzolamide + brimonidine in open-angle glaucoma (OAG), ocular hypertension, sponsored by Alcon Inc.. Started Oct 2013; status: completed.
02
Drugs
brinzolamide + brimonidine
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on NCT01978600.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01978600.